7º BioTech & eHealth - 10th Jun

Startups raising funds

• Debut, a San Diego-based synthetic biology startup focused on beauty product ingredients, raised $34m in Series B funding led by L'Oréal’s venture arm. Link
• Helium Health, a Nigerian provider of telemedicine and other digital solutions to African health care systems, raised $30m in Series B funding. AXA IM Alts led, and was joined by Anne Wojcicki, Capria Ventures, Angaza Capital, Flatworld Partners, Global Ventures, Tencent, Ohara Pharma, LCY Group, WTI and AAIC. Link
• Alkeus Pharmaceuticals, a Cambridge, Mass.-based biotech focused on treating a genetic cause of blindness, raised $150m in Series B funding. Bain Capital Life Sciences led, and was joined by TCGX, Wellington Management and Sofinnova Investments. Link
• Axuall, a Cleveland-based provider of clinical workforce tools, raised $20m in Series B funding. Noro-Moseley Partners led, and was joined by Flare Capital Partners, Intermountain Ventures, University Hospitals Ventures, Hartford HealthCare, LocumTenens.com, Epsilon Health Investors, InHealth Ventures, AV8 Ventures, JumpStart Ventures and M25 Ventures. Link
• RK Pharma, a Pearl River, N.Y.-based generic pharma developer focused on complex injectables, raised $200m from PAG. Link
• GetHarley, a London-based telehealth platform for skincare professionals, raised $52m. Index Ventures led, and was joined by Headline, Visionaries Club and Village Global. Link
• Grapefruit Health, a Chicago-based remote patient monitoring startup, raised $1.3m from backers like Google for Startups. Link
• Kate Therapeutics, a San Diego-based gene therapy startup, raised $51m in Series A funding. Westlake Village BioPartners and Versant Ventures co-led, and were joined by Osage University Partners and UF Innovate Ventures. It also signed a deal to let Astellas Pharma develop, manufacture and commercialize a drug candidate for treating X-linked myotubular myopathy. Link
• Pomelo Care, a New York-based virtual maternal and infant health medical practice, raised $33m in seed and Series A funding from Andreessen Horowitz, First Round Capital, SV Angel Operator Partners, Allen & Co. and BoxGroup. Link
• Laudio, a Newton, Mass.-based provider of health care operations management software, raised $13m in Series B funding. Define Ventures led, and was joined by insiders .406 Ventures, InHealth Ventures, MemorialCare Innovation Fund, and TeleTracking Technologies. Link
• Upstream Bio, a Waltham, Mass.-based developer of therapies to treat inflammation, raised $200m in Series B funding. Enavate Sciences and Venrock co-led, and were joined by Bain Capital Life Sciences, Wellington Management and insiders OrbiMed, Access Biotechnology, Decheng Capital, Altshuler Shaham Provident Funds, TCG X, HBM Healthcare Investments, Omega Funds and Samsara BioCapital. Link
• Carta Healthcare, an SF-based clinical data company, raised $25m in Series B funding from Memorial Hermann Health System and UnityPoint Health. Link

M&A and Private equity deals

• Calcium, a New York-based health care marketing agency owned by NexPhase Capital, acquired Boynton Beach, Fla.-based scientific communications agency CSG Health Group. Link
• Warburg Pincus invested in Pareto Health, a Philadelphia-based employee benefits platform, and will hold an equal stake with existing Pareto backer Great Hill Partners. Link
• General Electric (NYSE: GE) is planning to sell around a $2b stake in its health care tech unit, via a debt-for-equity swap. Link
• PSG made a growth investment in Loopback Analytics, a Dallas-based provider of health system and academic medical center analytics. Link

IPO

• Luz Saude, a health care unit of Portuguese insurer Fidelidade, is planning to raise at least €300m in its Lisbon IPO. Link
• CERo Therapeutics, a South SF-based developer of T-cell therapies that raised over $40m in VC funding, agreed to go public at an implied $145m valuation via Phoenix Biotech Acquisition Corp. (Nasdaq: PBAX) Link

Read the news of digital businesses by email each day at www.multiversial.es